Literature DB >> 18587597

Familial non-arteritic anterior ischemic optic neuropathy.

Sohan Singh Hayreh1, John H Fingert, Edwin Stone, Daniel M Jacobson.   

Abstract

PURPOSE: Primary objective was to investigate clinical characteristics of nonarteritic anterior ischemic optic neuropathy (NA-AION) in three families; secondarily, to test these families for a previously detected mitochondrial mutation in a pedigree with familial NA-AION.
METHODS: Study comprised three families where more than one member developed NA-AION. All patients with NA-AION had a detailed ophthalmic, medical and family history, and comprehensive ophthalmic evaluation at initial visit and on follow-up. One patient from family 1, one from family 2, 41 non-familial NA-AION patients, 97 control subjects and 1,488 patients with suspected Leber hereditary optic neuropathy (LHON) were tested for the presence of mitochondrial mutation (G4132A) in a previously reported genetic study of family 3.
RESULTS: Familial NA-AION was found in seven individuals of family 1, four of family 2 and six of family 3. Symptoms, signs and clinical findings of familial NA-AION were similar to classical NA-AION, with two exceptions: familial NA-AION had an earlier onset (47.3 + 8.6 years versus 60.1 + 13.6 years) and a higher frequency of bilateral disease. The G4132A mitochondrial variant was not detected outside family 3. None of the three major mutations associated with LHON (G3460A, G11778A, T14484C) was found among Familial NA-AION patients.
CONCLUSIONS: The only difference in clinical features between familial NA-AION and classical NA-AION is that the former has an earlier onset and a higher frequency of bilateral disease. The G4132A mutation is not commonly associated with familial NA-AION, and was not detected in patients with non-familial NA-AION. The role of hereditary factors in familial NA-AION remains largely unknown.

Entities:  

Mesh:

Year:  2008        PMID: 18587597     DOI: 10.1007/s00417-008-0853-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  29 in total

1.  Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations.

Authors:  K K Abu-Amero; T M Bosley
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-11

3.  Three cases of non-inflammatory ischemic optic neuropathy occurring in the same family.

Authors:  L Berggren; W Thorburn; H Fodstad
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

4.  Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy.

Authors:  O Salomon; R Huna-Baron; S Kurtz; D M Steinberg; J Moisseiev; N Rosenberg; I Yassur; O Vidne; A Zivelin; S Gitel; J Davidson; B Ravid; U Seligsohn
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

5.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

6.  Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman
Journal:  Arch Ophthalmol       Date:  2005-11

7.  Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.

Authors:  Gilles R Dagenais; Qilong Yi; Eva Lonn; Peter Sleight; Jan Ostergren; Salim Yusuf
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2005-02

8.  The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study.

Authors:  Nancy J Newman; Roberta Scherer; Patricia Langenberg; Shalom Kelman; Steven Feldon; David Kaufman; Kay Dickersin
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

9.  Incipient nonarteritic anterior ischemic optic neuropathy.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2007-03-27       Impact factor: 12.079

10.  MITOMAP: a human mitochondrial genome database--2004 update.

Authors:  Marty C Brandon; Marie T Lott; Kevin Cuong Nguyen; Syawal Spolim; Shamkant B Navathe; Pierre Baldi; Douglas C Wallace
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

View more
  4 in total

1.  Bilateral Non-Arteritic Anterior Ischaemic Optic Neuropathy in a Patient with a COL4A2 Mutation.

Authors:  Kasim Qureshi; Muhammad U Farooq; Avneet Deol; Christopher Glisson; Philip B Gorelick
Journal:  Neuroophthalmology       Date:  2021-10-25

2.  Genetic polymorphisms of apolipoprotein E in nonarteritic anterior ischemic optic neuropathy.

Authors:  Yuyu Chou; Zixi Sun; Ye Wang; Yuhan Wang; Jin Ma; Dianxi Zhang; Yong Zhong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-08       Impact factor: 3.535

3.  A case of nonarteritic anterior ischemic optic neuropathy of a male with family history of the disease after receiving sildenafil.

Authors:  T Felekis; I Asproudis; K Katsanos; Ev Tsianos
Journal:  Clin Ophthalmol       Date:  2011-10-07

4.  A case of recurrent transient monocular visual loss after receiving sildenafil.

Authors:  Asaad Ghanem Ghanem
Journal:  Case Rep Ophthalmol Med       Date:  2011-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.